Company / Shareholders' Equity
Centessa Pharmaceuticals plc Shareholders' Equity History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$526.9M
FY2025
5-year range
$236.2M / $526.9M
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#91 of 213
Health Care
What the data says
At $527M, Centessa Pharmaceuticals plc's shareholders' equity ranks #91 of 213 in the Health Care sector. Improved from $236M to $527M over the past 2 years.
Based on SEC 10-K filings.
$527M in FY2025 with a 3-year CAGR of +16.2%.
Improved from $236M to $527M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +16.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 213 in Health CareTop 43% of 213This company $526.9M Sector average $2.5B
▼
-79.3% below sector average
Key checks
Key Insights
- 3-year CAGR of +16.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 31.2% year-over-year.
- Ranks #91 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $526.9M | +31.2% |
| FY2024 | $401.5M | +70.0% |
| FY2023 | $236.2M | -29.7% |
| FY2022 | $336.2M | -31.6% |
| FY2021 | $491.6M | +10668.8% |
| FY2020 | -$4.7M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026